September 8th, 2010 by GarySchwitzer in Better Health Network, Health Policy, Health Tips, News, Opinion, Research
No Comments »
Journalist Andrew Holtz has been a colleague for longer than probably either one of us wants to remember. He is currently one of our story reviewers on HealthNewsReview.org. In fact, he was one of the reviewers on four stories we analyzed last week on the same study. He thought there were some important take-home messages that rose above the walls of our formal systematic review, so he wrote this guest blog post, and we thank him for it:
The Sept. 1 issue of the Journal of the American Medical Association included an article that is likely to have a strong influence on the advice given to women who have a very high risk of breast and ovarian cancer linked to mutations of the BRCA1 and BRCA2 genes. Of the four stories we reviewed, only the AP report scored well on our review criteria.
I know what my first journalism professor, Marion Lewenstein, would have done with at least two of the stories: Given them an “F” for factual errors without further consideration of their merits. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
August 27th, 2010 by RamonaBatesMD in Better Health Network, Health Policy, News, Opinion
No Comments »
Recently the [state of] New York signed a law requiring hospitals and doctors to discuss breast reconstruction options with the patient prior to her undergoing cancer surgery. It troubled me that this law was needed. Is it not the duty of the physicians and surgeons to educate the patient on the options available?
We need to make sure the patient and their family know of the treatment options which may vary depending on the diagnosis and stage: Radiation, chemotherapy, surgery (lumpectomy, mastectomy, axillary dissection) — a combination of treatments.
Even if the patient and her physicians don’t chose to do immediate reconstruction, isn’t the discussion and information part of the discussion? At least inform the patient of the option.
Do we physicians and surgeons need another law to ensure we do right by our patients? Read more »
*This blog post was originally published at Suture for a Living*
August 23rd, 2010 by RyanDuBosar in Better Health Network, Health Policy, News, Research
No Comments »
Cancer is the world’s costliest disease, sapping the equivalent of 1.5 percent of the global gross domestic product through disability and loss of life, according to the American Cancer Society (ACS). Cancer cost $895 billion in 2008, and that’s before factoring in the cost of treating cancer.
Cancer and other chronic diseases cost more than infectious diseases and even AIDS, according to a report the ACS [presented last] week. While chronic diseases are 60 percent of all deaths globally, they receive only 3 percent of private and public research funding. The organization is calling for a new look at priorities by the United Nations and the World Health Organization. (Associated Press)
*This blog post was originally published at ACP Internist*
August 21st, 2010 by AndrewSchorr in Better Health Network, News, Research, True Stories
No Comments »
There’s news that Hollywood star Michael Douglas, 65, is undergoing treatment for throat cancer. Reporters say his doctors say he is expected to make a full recovery. But, believe me — when someone is diagnosed with any kind of head and neck cancer, as this is, it’s not an easy go.
My first encounter with it was with my friend Bob Moore, a former sales rep for a major pharmaceutical company. He was a positive, yet realistic guy. The disease and the toxic treatment a few years ago eventually took its toll and he passed on.
My dear friend Mike Piller, famous as writer and co-executive producer of the Star Trek television series, had a similar diagnosis. He did his research and traveled to the best centers. Surgery and radiation took away part of his jaw and his ability to taste and swallow. Of course his speech was affected. He was a trooper, but he never recovered.
In both cases the doctors did what they could to cut out or zap the cancerous tissue tucked away around a lot of critical structures. Read more »
*This blog post was originally published at Andrew's Blog*
August 19th, 2010 by Debra Gordon in Better Health Network, Health Policy, News, Opinion, Research
No Comments »
Time to get back up on my soap box.
Next month the FDA is supposed to consider taking the unique, first-time-ever step of revoking a drug’s indication not because it’s dangerous, but because it doesn’t work well enough to offset its risks. Never mind that it costs about $8,000 a month.
The drug is Avastin (bevacizumab), a targeted monoclonal antibody that prevents tumors from creating and maintaining their own blood supply, a process called angiogenesis. Without oxygen and nutrients from blood, tumors can’t keep growing.
Avastin is the world’s best-selling cancer drug, approved for use with chemotherapy to treat lung cancer and metastatic colorectal and breast cancer. It is also being investigated (and, likely, being prescribed off label) for numerous other cancers. The problem comes with breast cancer. Read more »
*This blog post was originally published at A Medical Writer's Musings on Medicine, Health Care, and the Writing Life*
